Ignite Creation Date:
2025-12-24 @ 7:54 PM
Ignite Modification Date:
2026-01-01 @ 8:46 PM
Study NCT ID:
NCT04832204
Status:
UNKNOWN
Last Update Posted:
2021-04-05
First Post:
2021-04-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Apatinib Combined With SHR-1210 as Second-line Treatment in Solid Tumors With Only Liver Metastases
Sponsor:
Beijing Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-25
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-04
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-02
First Submit QC Date:
None
Study First Post Date:
2021-04-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-04-02
Last Update Post Date:
2021-04-05
Last Update Post Date Type:
ACTUAL